A dried blood spot protocol for high throughput analysis of SARS-CoV-2 serology based on the Roche Elecsys anti-N assay
Background: Since 2020 SARS-CoV-2 spreads pandemically, infecting more than 119 million people, causing >2·6 million fatalities. Symptoms of SARS-CoV-2 infection vary greatly, ranging from asymptomatic to fatal. Different populations react differently to the disease, making it very hard to track...
Main Authors: | Jessica Beyerl, Raquel Rubio-Acero, Noemi Castelletti, Ivana Paunovic, Inge Kroidl, Zohaib N. Khan, Abhishek Bakuli, Andreas Tautz, Judith Oft, Michael Hoelscher, Andreas Wieser |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-08-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396421002954 |
Similar Items
-
A Dried Blood Spot protocol for high-throughput quantitative analysis of SARS-CoV-2 RBD serology based on the Roche Elecsys system
by: Noemi Castelletti, et al.
Published: (2024-04-01) -
The development and validation of dried blood spots for external quality assurance of syphilis serology
by: Smit Pieter W, et al.
Published: (2013-02-01) -
Stability and Feasibility of Dried Blood Spots for Hepatitis E Virus Serology in a Rural Setting
by: Joakim Øverbø, et al.
Published: (2022-11-01) -
Impact of Omicron Variant Infection on Assessment of Spike-Specific Immune Responses Using the EUROIMMUN Quan-T-Cell SARS-CoV-2 Assay and Roche Elecsys Anti-SARS-CoV-2-S
by: Mohamed I. M. Ahmed, et al.
Published: (2023-03-01) -
At-home dried blood spot (DBS) collection to increase population heterogeneity representation in pediatric research: An ECHO study
by: Joseph M. Green, et al.
Published: (2023-03-01)